Fortis Life Sciences expands its international presence

Fortis Life Sciences is answering the demand for high-quality reagents and custom services for discovery, development, and manufacturing

23 Oct 2022
Blake Forman
Content Creator

Industry news

Fortis Life Sciences, a provider of high-quality reagents and custom services for discovery, development, and manufacturing, has expanded its international presence by opening an office in Seoul, South Korea.

South Korea's pharmaceutical, diagnostic, and life science industry has grown to become one of the most comprehensive markets in Asia-Pacific, with increased demand from within and outside the region. Therefore, this strategic milestone is a significant development to bolster Fortis’ commitment to serving the Asian marketplace and increasing its connection with this customer base.

Fortis appointed Young K. Yun, Ph.D. as APAC's Vice President and General Manager. Dr. Yun will run the Fortis Korea headquarters in Seoul, Korea. Brian Kim, CEO of Fortis, remarked, "I am honored to announce that Young Yun is joining Fortis as Vice President and General Manager of APAC and establishing our regional HQ in Seoul, Korea. Young brings a wealth of regional and industry—both MNC and start-up—experience making him uniquely qualified for this important role."

"With the expanded global demand and sophisticated supply chain in life science, diagnostic, and therapeutic markets, Fortis Life Sciences is answering scientists’ requests for faster turnaround time, the highest product quality, the best customer experience, and reliable scientific support," said Dr. Yun. "We are excited to partner with leading diagnostic and life science companies in the region that have a proven track record of delivering the most innovative products to biomedical researchers and clinicians at a global level."

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. Scale-upScale-Up is generally defined as the process of transferring the results of the discovery phases of the drug discovery process, obtained on a laboratory scale, to the pilot plant and finally to production scale. Scale-Up uses reactors and pump systems as well as reagents, standards and buffers. Often Scale-Up is provided as a service by Contract Manufacturing Organizations (CMOs). Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.
Fortis Life Sciences expands its international presence